REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmadax Inc. (法德生技药品股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmadax Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

pharmadax inc. is a pharmaceutical company with operations in the USA, China, and emerging countries. The company focuses on developing modified release generics in various therapeutic segments using high precision technology platforms for solid oral dosage forms. Pharmadax aims to bring quality pharmaceuticals with efficient technological advantage to the USA market at a reasonable price.

Headquarters
5F.-1, No.236, Liancheng Rd., Zhonghe District
New Taipei City; New Taipei City;

Contact Details: Purchase the Pharmadax Inc. (法德生技药品股份有限公司) report to view the information.

Website: http://www.pharmadax.com

Basic Information
Total Employees:
Purchase the Pharmadax Inc. (法德生技药品股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Pharmadax Inc. (法德生技药品股份有限公司) report to view the information.
Financial Auditors:
Purchase the Pharmadax Inc. (法德生技药品股份有限公司) report to view the information.
Incorporation Date:
March 21, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
4.31%
Purchase this report to view the information.
1.17%
Purchase this report to view the information.
1.03%
Purchase this report to view the information.
0.14%
Purchase this report to view the information.
0.02%
Subsidiaries
Pharmadax International Inc. (Samoa)
100%
勝群藥業股份有限公司
60%
Company Performance
Financial values in the chart are available after Pharmadax Inc. (法德生技药品股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
8.74%
Total Operating Revenue
8.73%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
-821.41%
Total Assets
-30.32%
Total Equity
22.68%
Operating Profit Margin
N/A
Net Profit Margin
-11.28%
Return on Equity (ROE)
12.32%
Debt / Equity
-34.76%
Quick Ratio
-0.3%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?